Pretransplantation patient characteristics
Characteristics . | MAT . | RIC . | P . |
|---|---|---|---|
| SCID, no. patients/total (%) | 7/19 (37) | 6/33 (18) | .41 |
| B+/B– | 1/5 | 1/3 | NA |
| Non-SCID, no. patients/total (%) | 12/19 (63) | 27/33 (82) | .41 |
| WAS | 1 | 4 | NA |
| T-cell deficiencies | 9 | 14 | NA |
| CD40 ligand deficiency | 2 | 4 | NA |
| Phagocytic disorders | 0 | 5 | NA |
| Median age at transplantation, y | 1.9 | 5.9 | .002 |
| MUD vs mMUD donors, % | 58 vs 42 | 67 vs 33 | NS |
| % Children with pulmonary complications | 74 | 55 | NS |
| % Children with hepatic complications | 26 | 30 | NS |
Characteristics . | MAT . | RIC . | P . |
|---|---|---|---|
| SCID, no. patients/total (%) | 7/19 (37) | 6/33 (18) | .41 |
| B+/B– | 1/5 | 1/3 | NA |
| Non-SCID, no. patients/total (%) | 12/19 (63) | 27/33 (82) | .41 |
| WAS | 1 | 4 | NA |
| T-cell deficiencies | 9 | 14 | NA |
| CD40 ligand deficiency | 2 | 4 | NA |
| Phagocytic disorders | 0 | 5 | NA |
| Median age at transplantation, y | 1.9 | 5.9 | .002 |
| MUD vs mMUD donors, % | 58 vs 42 | 67 vs 33 | NS |
| % Children with pulmonary complications | 74 | 55 | NS |
| % Children with hepatic complications | 26 | 30 | NS |
WAS indicates Wiscott-Aldrich syndrome; mMUD, mismatched unrelated donor; NA, not applicable; NS, not significant.